Cardio-Oncology: Understanding the Intersections Between Cardiac Metabolism and Cancer Biology

Overview

Journal JACC Basic Transl Sci

Date 2021 Sep 1

PMID 34466757

Citations 20

Authors

Anja Karlstaedt

Matthew Barrett

Ray Hu

Seth Thomas Gammons

Bonnie Ky

Affiliations

Soon will be listed here.

Abstract

An important priority in the cardiovascular care of oncology patients is to reduce morbidity and mortality, and improve the quality of life in cancer survivors through cross-disciplinary efforts. The rate of survival in cancer patients has improved dramatically over the past decades. Nonetheless, survivors may be more likely to die from cardiovascular disease in the long term, secondary, not only to the potential toxicity of cancer therapeutics, but also to the biology of cancer. In this context, efforts from basic and translational studies are crucial to understanding the molecular mechanisms causal to cardiovascular disease in cancer patients and survivors, and identifying new therapeutic targets that may prevent and treat both diseases. This review aims to highlight our current understanding of the metabolic interaction between cancer and the heart, including potential therapeutic targets. An overview of imaging techniques that can support both research studies and clinical management is also provided. Finally, this review highlights opportunities and challenges that are necessary to advance our understanding of metabolism in the context of cardio-oncology.

Citing Articles

Atrial Fibrillation in Patients with Breast Cancer: A Literature Review.

Bello M, Wadid M, Malode A, Patel V, Shah A, Vyas A Cardiol Ther. 2024; 14(1):1-15.

PMID: 39714744 PMC: 11893935. DOI: 10.1007/s40119-024-00394-1.

Metabolic syndrome and cardiovascular disease among adult cancer patients: results from NHANES 2007-2018.

Liu A, Zhang Y, Tian P, Meng T, Chen J, Zhang D BMC Public Health. 2024; 24(1):2259.

PMID: 39164696 PMC: 11337603. DOI: 10.1186/s12889-024-19659-4.

Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy.

Mao X, Wu S, Huang D, Li C Acta Pharm Sin B. 2024; 14(7):2901-2926.

PMID: 39027258 PMC: 11252465. DOI: 10.1016/j.apsb.2024.03.006.

Health Literacy, Individual and Community Engagement, and Cardiovascular Risks and Disparities: State-of-the-Art Review.

Taylor L, Hong A, Hahm K, Kim D, Smith-Morris C, Zaha V JACC CardioOncol. 2024; 6(3):363-380.

PMID: 38983375 PMC: 11229558. DOI: 10.1016/j.jaccao.2024.03.010.

Impact of hyperuricemia and chronic kidney disease on the prevalence and mortality of cardiovascular disease in cancer survivors.

Chen Y, Chen Y, Lin W, Fu L, Liu H, Pu S Cancer Med. 2024; 13(9):e7180.

PMID: 38686569 PMC: 11058684. DOI: 10.1002/cam4.7180.

References

Meijers W, Maglione M, Bakker S, Oberhuber R, Kieneker L, de Jong S . Heart Failure Stimulates Tumor Growth by Circulating Factors. Circulation. 2018; 138(7):678-691. DOI: 10.1161/CIRCULATIONAHA.117.030816. View

Nekolla S, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A . Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009; 119(17):2333-42. DOI: 10.1161/CIRCULATIONAHA.108.797761. View

Viale A, Pettazzoni P, Lyssiotis C, Ying H, Sanchez N, Marchesini M . Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 2014; 514(7524):628-32. PMC: 4376130. DOI: 10.1038/nature13611. View

Schroeder M, Lau A, Chen A, Gu Y, Nagendran J, Barry J . Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart. Eur J Heart Fail. 2012; 15(2):130-40. PMC: 3547367. DOI: 10.1093/eurjhf/hfs192. View

Hopkins B, Pauli C, Du X, Wang D, Li X, Wu D . Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018; 560(7719):499-503. PMC: 6197057. DOI: 10.1038/s41586-018-0343-4. View

Chen H, Orozco L, Wang J, Rau C, Rubbi L, Ren S . DNA Methylation Indicates Susceptibility to Isoproterenol-Induced Cardiac Pathology and Is Associated With Chromatin States. Circ Res. 2016; 118(5):786-97. PMC: 4779427. DOI: 10.1161/CIRCRESAHA.115.305298. View

Schoonjans C, Mathieu B, Joudiou N, Zampieri L, Brusa D, Sonveaux P . Targeting Endothelial Cell Metabolism by Inhibition of Pyruvate Dehydrogenase Kinase and Glutaminase-1. J Clin Med. 2020; 9(10). PMC: 7602423. DOI: 10.3390/jcm9103308. View

Szablewski L . Glucose transporters in healthy heart and in cardiac disease. Int J Cardiol. 2016; 230:70-75. DOI: 10.1016/j.ijcard.2016.12.083. View

Klabunde R . Cardiac electrophysiology: normal and ischemic ionic currents and the ECG. Adv Physiol Educ. 2017; 41(1):29-37. DOI: 10.1152/advan.00105.2016. View

10.

Bedi Jr K, Snyder N, Brandimarto J, Aziz M, Mesaros C, Worth A . Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure. Circulation. 2016; 133(8):706-16. PMC: 4779339. DOI: 10.1161/CIRCULATIONAHA.115.017545. View

11.

Thorens B, Mueckler M . Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab. 2009; 298(2):E141-5. PMC: 2822486. DOI: 10.1152/ajpendo.00712.2009. View

12.

Borniger J, Walker Ii W, Surbhi , Emmer K, Zhang N, Zalenski A . A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Cancer. Cell Metab. 2018; 28(1):118-129.e5. PMC: 6031468. DOI: 10.1016/j.cmet.2018.04.021. View

13.

Salabei J, Lorkiewicz P, Holden C, Li Q, Hong K, Bolli R . Glutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation. Stem Cells. 2015; 33(8):2613-27. PMC: 4509862. DOI: 10.1002/stem.2047. View

14.

Ferrannini E, Baldi S, Frascerra S, Astiarraga B, Heise T, Bizzotto R . Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes. Diabetes. 2016; 65(5):1190-5. DOI: 10.2337/db15-1356. View

15.

Totzeck M, Schuler M, Stuschke M, Heusch G, Rassaf T . Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease. Int J Cardiol. 2019; 280:163-175. DOI: 10.1016/j.ijcard.2019.01.038. View

16.

Morin A, Goncalves J, Moog S, Castro-Vega L, Job S, Buffet A . TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition. Cell Rep. 2020; 30(13):4551-4566.e7. DOI: 10.1016/j.celrep.2020.03.022. View

17.

Hesketh R, Brindle K . Magnetic resonance imaging of cancer metabolism with hyperpolarized C-labeled cell metabolites. Curr Opin Chem Biol. 2018; 45:187-194. DOI: 10.1016/j.cbpa.2018.03.004. View

18.

Fulop N, Marchase R, Chatham J . Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res. 2006; 73(2):288-97. PMC: 2848961. DOI: 10.1016/j.cardiores.2006.07.018. View

19.

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

20.

Armenian S, Gelehrter S, Vase T, Venkatramani R, Landier W, Wilson K . Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines. Cancer Epidemiol Biomarkers Prev. 2014; 23(6):1109-14. PMC: 4053243. DOI: 10.1158/1055-9965.EPI-13-1384. View